TY - JOUR AU - Greig, S. L. PY - 2015 DA - 2015// TI - Talimogene laherparepvec: first global approval JO - Drugs ID - Greig2015 ER - TY - JOUR AU - Ranki, T. AU - Joensuu, T. AU - Jager, E. AU - Karbach, J. AU - Wahle, C. AU - Kairemo, K. PY - 2014 DA - 2014// TI - Local treatment of a pleural mesothelioma tumor with ONCOS-102 induces a systemic antitumor CD8 T-cell response, prominent infiltration of CD8 lymphocytes and Th1 type polarization JO - Oncoimmunology VL - 3 UR - https://doi.org/10.4161/21624011.2014.958937 DO - 10.4161/21624011.2014.958937 ID - Ranki2014 ER - TY - JOUR AU - Vassilev, L. AU - Ranki, T. AU - Joensuu, T. AU - Jager, E. AU - Karbach, J. AU - Wahle, C. PY - 2015 DA - 2015// TI - Repeated intratumoral administration of ONCOS-102 leads to systemic antitumor CD8 T-cell response and robust cellular and transcriptional immune activation at tumor site in a patient with ovarian cancer JO - Oncoimmunology VL - 4 UR - https://doi.org/10.1080/2162402X.2015.1017702 DO - 10.1080/2162402X.2015.1017702 ID - Vassilev2015 ER - TY - JOUR AU - Fridman, W. H. AU - Galon, J. AU - Dieu-Nosjean, M. C. AU - Cremer, I. AU - Fisson, S. AU - Damotte, D. PY - 2011 DA - 2011// TI - Immune infiltration in human cancer: prognostic significance and disease control JO - Curr Top Microbiol Immunol VL - 344 ID - Fridman2011 ER - TY - JOUR AU - Pages, F. AU - Galon, J. AU - Dieu-Nosjean, M. C. AU - Tartour, E. AU - Sautes-Fridman, C. AU - Fridman, W. H. PY - 2010 DA - 2010// TI - Immune infiltration in human tumors: a prognostic factor that should not be ignored JO - Oncogene VL - 29 UR - https://doi.org/10.1038/onc.2009.416 DO - 10.1038/onc.2009.416 ID - Pages2010 ER - TY - JOUR AU - Galon, J. AU - Costes, A. AU - Sanchez-Cabo, F. AU - Kirilovsky, A. AU - Mlecnik, B. AU - Lagorce-Pages, C. PY - 2006 DA - 2006// TI - Type, density, and location of immune cells within human colorectal tumors predict clinical outcome JO - Science VL - 313 UR - https://doi.org/10.1126/science.1129139 DO - 10.1126/science.1129139 ID - Galon2006 ER - TY - JOUR AU - Tumeh, P. C. AU - Harview, C. L. AU - Yearley, J. H. AU - Shintaku, I. P. AU - Taylor, E. J. AU - Robert, L. PY - 2014 DA - 2014// TI - PD-1 blockade induces responses by inhibiting adaptive immune resistance JO - Nature VL - 515 UR - https://doi.org/10.1038/nature13954 DO - 10.1038/nature13954 ID - Tumeh2014 ER - TY - JOUR AU - Yadav, M. AU - Jhunjhunwala, S. AU - Phung, Q. T. AU - Lupardus, P. AU - Tanguay, J. AU - Bumbaca, S. PY - 2014 DA - 2014// TI - Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing JO - Nature VL - 515 UR - https://doi.org/10.1038/nature14001 DO - 10.1038/nature14001 ID - Yadav2014 ER - TY - JOUR AU - Workenhe, S. T. AU - Mossman, K. L. PY - 2013 DA - 2013// TI - Rewiring cancer cell death to enhance oncolytic viro-immunotherapy JO - Oncoimmunology VL - 2 UR - https://doi.org/10.4161/onci.27138 DO - 10.4161/onci.27138 ID - Workenhe2013 ER - TY - JOUR AU - Draper, S. J. AU - Heeney, J. L. PY - 2010 DA - 2010// TI - Viruses as vaccine vectors for infectious diseases and cancer JO - Nat Rev Microbiol VL - 8 UR - https://doi.org/10.1038/nrmicro2240 DO - 10.1038/nrmicro2240 ID - Draper2010 ER - TY - JOUR AU - Majhen, D. AU - Calderon, H. AU - Chandra, N. AU - Fajardo, C. A. AU - Rajan, A. AU - Alemany, R. PY - 2014 DA - 2014// TI - Adenovirus-based vaccines for fighting infectious diseases and cancer: progress in the field JO - Hum Gene Ther VL - 25 UR - https://doi.org/10.1089/hum.2013.235 DO - 10.1089/hum.2013.235 ID - Majhen2014 ER - TY - JOUR AU - Bridle, B. W. AU - Hanson, S. AU - Lichty, B. D. PY - 2010 DA - 2010// TI - Combining oncolytic virotherapy and tumour vaccination JO - Cytokine Growth Factor Rev VL - 21 UR - https://doi.org/10.1016/j.cytogfr.2010.02.009 DO - 10.1016/j.cytogfr.2010.02.009 ID - Bridle2010 ER - TY - JOUR AU - Koski, A. AU - Kangasniemi, L. AU - Escutenaire, S. AU - Pesonen, S. AU - Cerullo, V. AU - Diaconu, I. PY - 2010 DA - 2010// TI - Treatment of cancer patients with a serotype 5/3 chimeric oncolytic adenovirus expressing GMCSF JO - Mol Ther VL - 18 UR - https://doi.org/10.1038/mt.2010.161 DO - 10.1038/mt.2010.161 ID - Koski2010 ER - TY - JOUR AU - Dranoff, G. PY - 2002 DA - 2002// TI - GM-CSF-based cancer vaccines JO - Immunol Rev VL - 188 UR - https://doi.org/10.1034/j.1600-065X.2002.18813.x DO - 10.1034/j.1600-065X.2002.18813.x ID - Dranoff2002 ER - TY - JOUR AU - Laar, L. AU - Coffer, P. J. AU - Woltman, A. M. PY - 2012 DA - 2012// TI - Regulation of dendritic cell development by GM-CSF: molecular control and implications for immune homeostasis and therapy JO - Blood VL - 119 UR - https://doi.org/10.1182/blood-2011-11-370130 DO - 10.1182/blood-2011-11-370130 ID - Laar2012 ER - TY - JOUR AU - Heise, C. AU - Hermiston, T. AU - Johnson, L. AU - Brooks, G. AU - Sampson-Johannes, A. AU - Williams, A. PY - 2000 DA - 2000// TI - An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy JO - Nat Med VL - 6 UR - https://doi.org/10.1038/80474 DO - 10.1038/80474 ID - Heise2000 ER - TY - JOUR AU - Cripe, T. P. AU - Ngo, M. C. AU - Geller, J. I. AU - Louis, C. U. AU - Currier, M. A. AU - Racadio, J. M. PY - 2015 DA - 2015// TI - Phase 1 study of intratumoral Pexa-Vec (JX-594), an oncolytic and immunotherapeutic vaccinia virus, in pediatric cancer patients JO - Mol Ther VL - 23 UR - https://doi.org/10.1038/mt.2014.243 DO - 10.1038/mt.2014.243 ID - Cripe2015 ER - TY - JOUR AU - Heo, J. AU - Breitbach, C. J. AU - Moon, A. AU - Kim, C. W. AU - Patt, R. AU - Kim, M. K. PY - 2011 DA - 2011// TI - Sequential therapy with JX-594, a targeted oncolytic poxvirus, followed by sorafenib in hepatocellular carcinoma: preclinical and clinical demonstration of combination efficacy JO - Mol Ther VL - 19 UR - https://doi.org/10.1038/mt.2011.39 DO - 10.1038/mt.2011.39 ID - Heo2011 ER - TY - JOUR AU - Hwang, T. H. AU - Moon, A. AU - Burke, J. AU - Ribas, A. AU - Stephenson, J. AU - Breitbach, C. J. PY - 2011 DA - 2011// TI - A mechanistic proof-of-concept clinical trial with JX-594, a targeted multi-mechanistic oncolytic poxvirus, in patients with metastatic melanoma JO - Mol Ther VL - 19 UR - https://doi.org/10.1038/mt.2011.132 DO - 10.1038/mt.2011.132 ID - Hwang2011 ER - TY - JOUR AU - Kaufman, H. L. AU - Kim, D. W. AU - DeRaffele, G. AU - Mitcham, J. AU - Coffin, R. S. AU - Kim-Schulze, S. PY - 2010 DA - 2010// TI - Local and distant immunity induced by intralesional vaccination with an oncolytic herpes virus encoding GM-CSF in patients with stage IIIc and IV melanoma JO - Ann Surg Oncol VL - 17 UR - https://doi.org/10.1245/s10434-009-0809-6 DO - 10.1245/s10434-009-0809-6 ID - Kaufman2010 ER - TY - JOUR AU - Alexandrov, L. B. AU - Nik-Zainal, S. AU - Wedge, D. C. AU - Aparicio, S. A. AU - Behjati, S. AU - Biankin, A. V. PY - 2013 DA - 2013// TI - Signatures of mutational processes in human cancer JO - Nature VL - 500 UR - https://doi.org/10.1038/nature12477 DO - 10.1038/nature12477 ID - Alexandrov2013 ER - TY - JOUR AU - Harty, J. T. AU - Badovinac, V. P. PY - 2008 DA - 2008// TI - Shaping and reshaping CD8+ T-cell memory JO - Nat Rev Immunol VL - 8 UR - https://doi.org/10.1038/nri2251 DO - 10.1038/nri2251 ID - Harty2008 ER - TY - JOUR AU - Alemany, R. AU - Suzuki, K. AU - Curiel, D. T. PY - 2000 DA - 2000// TI - Blood clearance rates of adenovirus type 5 in mice JO - J Gen Virol VL - 81 UR - https://doi.org/10.1099/0022-1317-81-11-2605 DO - 10.1099/0022-1317-81-11-2605 ID - Alemany2000 ER - TY - JOUR AU - Kawai, O. AU - Ishii, G. AU - Kubota, K. AU - Murata, Y. AU - Naito, Y. AU - Mizuno, T. PY - 2008 DA - 2008// TI - Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer JO - Cancer VL - 113 UR - https://doi.org/10.1002/cncr.23712 DO - 10.1002/cncr.23712 ID - Kawai2008 ER - TY - JOUR AU - Melichar, B. AU - Studentova, H. AU - Kalabova, H. AU - Vitaskova, D. AU - Cermakova, P. AU - Hornychova, H. PY - 2014 DA - 2014// TI - Predictive and prognostic significance of tumor-infiltrating lymphocytes in patients with breast cancer treated with neoadjuvant systemic therapy JO - Anticancer Res VL - 34 ID - Melichar2014 ER - TY - JOUR AU - Piersma, S. J. AU - Jordanova, E. S. AU - Poelgeest, M. I. AU - Kwappenberg, K. M. AU - Hulst, J. M. AU - Drijfhout, J. W. PY - 2007 DA - 2007// TI - High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer JO - Cancer Res VL - 67 UR - https://doi.org/10.1158/0008-5472.CAN-06-3388 DO - 10.1158/0008-5472.CAN-06-3388 ID - Piersma2007 ER - TY - JOUR AU - Yamada, N. AU - Oizumi, S. AU - Kikuchi, E. AU - Shinagawa, N. AU - Konishi-Sakakibara, J. AU - Ishimine, A. PY - 2010 DA - 2010// TI - CD8+ tumor-infiltrating lymphocytes predict favorable prognosis in malignant pleural mesothelioma after resection JO - Cancer Immunol Immunother VL - 59 UR - https://doi.org/10.1007/s00262-010-0881-6 DO - 10.1007/s00262-010-0881-6 ID - Yamada2010 ER - TY - JOUR AU - Balermpas, P. AU - Michel, Y. AU - Wagenblast, J. AU - Seitz, O. AU - Weiss, C. AU - Rodel, F. PY - 2014 DA - 2014// TI - Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer JO - Br J Cancer VL - 110 UR - https://doi.org/10.1038/bjc.2013.640 DO - 10.1038/bjc.2013.640 ID - Balermpas2014 ER - TY - JOUR AU - Kurahara, H. AU - Shinchi, H. AU - Mataki, Y. AU - Maemura, K. AU - Noma, H. AU - Kubo, F. PY - 2011 DA - 2011// TI - Significance of M2-polarized tumor-associated macrophage in pancreatic cancer JO - J Surg Res VL - 167 UR - https://doi.org/10.1016/j.jss.2009.05.026 DO - 10.1016/j.jss.2009.05.026 ID - Kurahara2011 ER - TY - JOUR AU - Weber, M. AU - Buttner-Herold, M. AU - Hyckel, P. AU - Moebius, P. AU - Distel, L. AU - Ries, J. PY - 2014 DA - 2014// TI - Small oral squamous cell carcinomas with nodal lymphogenic metastasis show increased infiltration of M2 polarized macrophages--an immunohistochemical analysis JO - J Craniomaxillofac Surg VL - 42 UR - https://doi.org/10.1016/j.jcms.2014.01.035 DO - 10.1016/j.jcms.2014.01.035 ID - Weber2014 ER - TY - JOUR AU - Wehrhan, F. AU - Buttner-Herold, M. AU - Hyckel, P. AU - Moebius, P. AU - Preidl, R. AU - Distel, L. PY - 2014 DA - 2014// TI - Increased malignancy of oral squamous cell carcinomas (oscc) is associated with macrophage polarization in regional lymph nodes - an immunohistochemical study JO - BMC Cancer VL - 14 UR - https://doi.org/10.1186/1471-2407-14-522 DO - 10.1186/1471-2407-14-522 ID - Wehrhan2014 ER - TY - JOUR AU - Martin, F. AU - Chan, A. C. PY - 2006 DA - 2006// TI - B cell immunobiology in disease: evolving concepts from the clinic JO - Annu Rev Immunol VL - 24 UR - https://doi.org/10.1146/annurev.immunol.24.021605.090517 DO - 10.1146/annurev.immunol.24.021605.090517 ID - Martin2006 ER - TY - JOUR AU - Nielsen, J. S. AU - Nelson, B. H. PY - 2012 DA - 2012// TI - Tumor-infiltrating B cells and T cells: Working together to promote patient survival JO - Oncoimmunology VL - 1 UR - https://doi.org/10.4161/onci.21650 DO - 10.4161/onci.21650 ID - Nielsen2012 ER - TY - JOUR AU - Nielsen, J. S. AU - Sahota, R. A. AU - Milne, K. AU - Kost, S. E. AU - Nesslinger, N. J. AU - Watson, P. H. PY - 2012 DA - 2012// TI - CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-12-0234 DO - 10.1158/1078-0432.CCR-12-0234 ID - Nielsen2012 ER - TY - JOUR AU - Tang, J. AU - Olive, M. AU - Pulmanausahakul, R. AU - Schnell, M. AU - Flomenberg, N. AU - Eisenlohr, L. PY - 2006 DA - 2006// TI - Human CD8+ cytotoxic T cell responses to adenovirus capsid proteins JO - Virology VL - 350 UR - https://doi.org/10.1016/j.virol.2006.01.024 DO - 10.1016/j.virol.2006.01.024 ID - Tang2006 ER - TY - JOUR AU - Galon, J. AU - Pages, F. AU - Marincola, F. M. AU - Thurin, M. AU - Trinchieri, G. AU - Fox, B. A. PY - 2012 DA - 2012// TI - The immune score as a new possible approach for the classification of cancer JO - J Transl Med VL - 10 UR - https://doi.org/10.1186/1479-5876-10-1 DO - 10.1186/1479-5876-10-1 ID - Galon2012 ER - TY - JOUR AU - Brahmer, J. R. PY - 2012 DA - 2012// TI - PD-1-targeted immunotherapy: recent clinical findings JO - Clin Adv Hematol Oncol VL - 10 ID - Brahmer2012 ER - TY - JOUR AU - Hamid, O. AU - Robert, C. AU - Daud, A. AU - Hodi, F. S. AU - Hwu, W. J. AU - Kefford, R. PY - 2013 DA - 2013// TI - Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1305133 DO - 10.1056/NEJMoa1305133 ID - Hamid2013 ER - TY - JOUR AU - Herbst, R. S. AU - Soria, J. C. AU - Kowanetz, M. AU - Fine, G. D. AU - Hamid, O. AU - Gordon, M. S. PY - 2014 DA - 2014// TI - Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients JO - Nature VL - 515 UR - https://doi.org/10.1038/nature14011 DO - 10.1038/nature14011 ID - Herbst2014 ER - TY - STD TI - Pico de Coana Y, Choudhury A, Kiessling R. Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system. Trends in molecular medicine. 2015. doi:10.1016/j.molmed.2015.05.005. ID - ref40 ER - TY - JOUR AU - Powles, T. AU - Eder, J. P. AU - Fine, G. D. AU - Braiteh, F. S. AU - Loriot, Y. AU - Cruz, C. PY - 2014 DA - 2014// TI - MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer JO - Nature VL - 515 UR - https://doi.org/10.1038/nature13904 DO - 10.1038/nature13904 ID - Powles2014 ER - TY - JOUR AU - Topalian, S. L. AU - Hodi, F. S. AU - Brahmer, J. R. AU - Gettinger, S. N. AU - Smith, D. C. AU - McDermott, D. F. PY - 2012 DA - 2012// TI - Safety, activity, and immune correlates of anti-PD-1 antibody in cancer JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1200690 DO - 10.1056/NEJMoa1200690 ID - Topalian2012 ER - TY - JOUR AU - Taube, J. M. AU - Anders, R. A. AU - Young, G. D. AU - Xu, H. AU - Sharma, R. AU - McMiller, T. L. PY - 2012 DA - 2012// TI - Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape JO - Sci Transl Med VL - 4 UR - https://doi.org/10.1126/scitranslmed.3003689 DO - 10.1126/scitranslmed.3003689 ID - Taube2012 ER - TY - JOUR AU - Bald, T. AU - Landsberg, J. AU - Lopez-Ramos, D. AU - Renn, M. AU - Glodde, N. AU - Jansen, P. PY - 2014 DA - 2014// TI - Immune cell-poor melanomas benefit from PD-1 blockade after targeted type I IFN activation JO - Cancer discovery VL - 4 UR - https://doi.org/10.1158/2159-8290.CD-13-0458 DO - 10.1158/2159-8290.CD-13-0458 ID - Bald2014 ER - TY - JOUR AU - Burke, J. M. AU - Lamm, D. L. AU - Meng, M. V. AU - Nemunaitis, J. J. AU - Stephenson, J. J. AU - Arseneau, J. C. PY - 2012 DA - 2012// TI - A first in human phase 1 study of CG0070, a GM-CSF expressing oncolytic adenovirus, for the treatment of nonmuscle invasive bladder cancer JO - J Urol VL - 188 UR - https://doi.org/10.1016/j.juro.2012.07.097 DO - 10.1016/j.juro.2012.07.097 ID - Burke2012 ER - TY - JOUR AU - Chiocca, E. A. AU - Abbed, K. M. AU - Tatter, S. AU - Louis, D. N. AU - Hochberg, F. H. AU - Barker, F. PY - 2004 DA - 2004// TI - A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting JO - Mol Ther VL - 10 UR - https://doi.org/10.1016/j.ymthe.2004.07.021 DO - 10.1016/j.ymthe.2004.07.021 ID - Chiocca2004 ER - TY - JOUR AU - Li, J. L. AU - Liu, H. L. AU - Zhang, X. R. AU - Xu, J. P. AU - Hu, W. K. AU - Liang, M. PY - 2009 DA - 2009// TI - A phase I trial of intratumoral administration of recombinant oncolytic adenovirus overexpressing HSP70 in advanced solid tumor patients JO - Gene Ther VL - 16 UR - https://doi.org/10.1038/gt.2008.179 DO - 10.1038/gt.2008.179 ID - Li2009 ER - TY - JOUR AU - Zaiss, A. K. AU - Machado, H. B. AU - Herschman, H. R. PY - 2009 DA - 2009// TI - The influence of innate and pre-existing immunity on adenovirus therapy JO - J Cell Biochem VL - 108 UR - https://doi.org/10.1002/jcb.22328 DO - 10.1002/jcb.22328 ID - Zaiss2009 ER - TY - JOUR AU - Alzuguren, P. AU - Hervas-Stubbs, S. AU - Gonzalez-Aseguinolaza, G. AU - Poutou, J. AU - Fortes, P. AU - Mancheno, U. PY - 2015 DA - 2015// TI - Transient depletion of specific immune cell populations to improve adenovirus-mediated transgene expression in the liver JO - Liver Int VL - 35 UR - https://doi.org/10.1111/liv.12571 DO - 10.1111/liv.12571 ID - Alzuguren2015 ER - TY - JOUR AU - Haisma, H. J. AU - Bellu, A. R. PY - 2011 DA - 2011// TI - Pharmacological interventions for improving adenovirus usage in gene therapy JO - Mol Pharm VL - 8 UR - https://doi.org/10.1021/mp100310h DO - 10.1021/mp100310h ID - Haisma2011 ER - TY - JOUR AU - Raper, S. E. AU - Chirmule, N. AU - Lee, F. S. AU - Wivel, N. A. AU - Bagg, A. AU - Gao, G. P. PY - 2003 DA - 2003// TI - Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer JO - Mol Genet Metab VL - 80 UR - https://doi.org/10.1016/j.ymgme.2003.08.016 DO - 10.1016/j.ymgme.2003.08.016 ID - Raper2003 ER - TY - JOUR AU - Sato, E. AU - Olson, S. H. AU - Ahn, J. AU - Bundy, B. AU - Nishikawa, H. AU - Qian, F. PY - 2005 DA - 2005// TI - Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer JO - Proc Natl Acad Sci U S A VL - 102 UR - https://doi.org/10.1073/pnas.0509182102 DO - 10.1073/pnas.0509182102 ID - Sato2005 ER - TY - JOUR AU - Tjin, E. P. AU - Luiten, R. M. PY - 2014 DA - 2014// TI - Tumor-infiltrating T-cells: important players in clinical outcome of advanced melanoma patients JO - Oncoimmunology VL - 3 UR - https://doi.org/10.4161/21624011.2014.954862 DO - 10.4161/21624011.2014.954862 ID - Tjin2014 ER - TY - JOUR AU - Spranger, S. AU - Spaapen, R. M. AU - Zha, Y. AU - Williams, J. AU - Meng, Y. AU - Ha, T. T. PY - 2013 DA - 2013// TI - Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells JO - Sci Transl Med VL - 5 UR - https://doi.org/10.1126/scitranslmed.3006504 DO - 10.1126/scitranslmed.3006504 ID - Spranger2013 ER - TY - JOUR AU - Schietinger, A. AU - Greenberg, P. D. PY - 2014 DA - 2014// TI - Tolerance and exhaustion: defining mechanisms of T cell dysfunction JO - Trends Immunol VL - 35 UR - https://doi.org/10.1016/j.it.2013.10.001 DO - 10.1016/j.it.2013.10.001 ID - Schietinger2014 ER - TY - JOUR AU - Zippelius, A. AU - Batard, P. AU - Rubio-Godoy, V. AU - Bioley, G. AU - Lienard, D. AU - Lejeune, F. PY - 2004 DA - 2004// TI - Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance JO - Cancer Res VL - 64 UR - https://doi.org/10.1158/0008-5472.CAN-03-3066 DO - 10.1158/0008-5472.CAN-03-3066 ID - Zippelius2004 ER - TY - JOUR AU - Salek-Ardakani, S. AU - Schoenberger, S. P. PY - 2013 DA - 2013// TI - T cell exhaustion: a means or an end? JO - Nat Immunol VL - 14 UR - https://doi.org/10.1038/ni.2619 DO - 10.1038/ni.2619 ID - Salek-Ardakani2013 ER - TY - JOUR AU - Wherry, E. J. PY - 2011 DA - 2011// TI - T cell exhaustion JO - Nat Immunol VL - 12 UR - https://doi.org/10.1038/ni.2035 DO - 10.1038/ni.2035 ID - Wherry2011 ER - TY - JOUR AU - Ahmadzadeh, M. AU - Johnson, L. A. AU - Heemskerk, B. AU - Wunderlich, J. R. AU - Dudley, M. E. AU - White, D. E. PY - 2009 DA - 2009// TI - Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired JO - Blood VL - 114 UR - https://doi.org/10.1182/blood-2008-12-195792 DO - 10.1182/blood-2008-12-195792 ID - Ahmadzadeh2009 ER - TY - JOUR AU - Jacobs, J. F. AU - Idema, A. J. AU - Bol, K. F. AU - Nierkens, S. AU - Grauer, O. M. AU - Wesseling, P. PY - 2009 DA - 2009// TI - Regulatory T cells and the PD-L1/PD-1 pathway mediate immune suppression in malignant human brain tumors JO - Neuro Oncol VL - 11 UR - https://doi.org/10.1215/15228517-2008-104 DO - 10.1215/15228517-2008-104 ID - Jacobs2009 ER - TY - JOUR AU - Ladanyi, A. AU - Somlai, B. AU - Gilde, K. AU - Fejos, Z. AU - Gaudi, I. AU - Timar, J. PY - 2004 DA - 2004// TI - T-cell activation marker expression on tumor-infiltrating lymphocytes as prognostic factor in cutaneous malignant melanoma JO - Clin Cancer Res VL - 10 UR - https://doi.org/10.1158/1078-0432.CCR-1161-03 DO - 10.1158/1078-0432.CCR-1161-03 ID - Ladanyi2004 ER - TY - JOUR AU - Zubieta, M. R. AU - Furman, D. AU - Barrio, M. AU - Bravo, A. I. AU - Domenichini, E. AU - Mordoh, J. PY - 2006 DA - 2006// TI - Galectin-3 expression correlates with apoptosis of tumor-associated lymphocytes in human melanoma biopsies JO - Am J Pathol VL - 168 UR - https://doi.org/10.2353/ajpath.2006.050971 DO - 10.2353/ajpath.2006.050971 ID - Zubieta2006 ER - TY - JOUR AU - Spel, L. AU - Boelens, J. J. AU - Nierkens, S. AU - Boes, M. PY - 2013 DA - 2013// TI - Antitumor immune responses mediated by dendritic cells: How signals derived from dying cancer cells drive antigen cross-presentation JO - Oncoimmunology VL - 2 UR - https://doi.org/10.4161/onci.26403 DO - 10.4161/onci.26403 ID - Spel2013 ER - TY - JOUR AU - Tesniere, A. AU - Apetoh, L. AU - Ghiringhelli, F. AU - Joza, N. AU - Panaretakis, T. AU - Kepp, O. PY - 2008 DA - 2008// TI - Immunogenic cancer cell death: a key-lock paradigm JO - Curr Opin Immunol VL - 20 UR - https://doi.org/10.1016/j.coi.2008.05.007 DO - 10.1016/j.coi.2008.05.007 ID - Tesniere2008 ER - TY - JOUR AU - Liikanen, I. AU - Ahtiainen, L. AU - Hirvinen, M. L. AU - Bramante, S. AU - Cerullo, V. AU - Nokisalmi, P. PY - 2013 DA - 2013// TI - Oncolytic adenovirus with temozolomide induces autophagy and antitumor immune responses in cancer patients JO - Mol Ther VL - 21 UR - https://doi.org/10.1038/mt.2013.51 DO - 10.1038/mt.2013.51 ID - Liikanen2013 ER - TY - JOUR AU - Donizy, P. AU - Kaczorowski, M. AU - Halon, A. AU - Leskiewicz, M. AU - Kozyra, C. AU - Matkowski, R. PY - 2015 DA - 2015// TI - Paucity of tumor-infiltrating lymphocytes is an unfavorable prognosticator and predicts lymph node metastases in cutaneous melanoma patients JO - Anticancer Res VL - 35 ID - Donizy2015 ER - TY - JOUR AU - Bartlett, D. L. AU - Liu, Z. AU - Sathaiah, M. AU - Ravindranathan, R. AU - Guo, Z. AU - He, Y. PY - 2013 DA - 2013// TI - Oncolytic viruses as therapeutic cancer vaccines JO - Mol Cancer VL - 12 UR - https://doi.org/10.1186/1476-4598-12-103 DO - 10.1186/1476-4598-12-103 ID - Bartlett2013 ER - TY - JOUR AU - Holzel, M. AU - Bovier, A. AU - Tuting, T. PY - 2013 DA - 2013// TI - Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance? JO - Nat Rev Cancer VL - 13 UR - https://doi.org/10.1038/nrc3498 DO - 10.1038/nrc3498 ID - Holzel2013 ER - TY - JOUR AU - Patel, S. P. AU - Kurzrock, R. PY - 2015 DA - 2015// TI - PD-L1 expression as a predictive biomarker in cancer immunotherapy JO - Mol Cancer Ther VL - 14 UR - https://doi.org/10.1158/1535-7163.MCT-14-0983 DO - 10.1158/1535-7163.MCT-14-0983 ID - Patel2015 ER - TY - JOUR AU - Johnson, W. E. AU - Li, C. AU - Rabinovic, A. PY - 2007 DA - 2007// TI - Adjusting batch effects in microarray expression data using empirical Bayes methods JO - Biostatistics VL - 8 UR - https://doi.org/10.1093/biostatistics/kxj037 DO - 10.1093/biostatistics/kxj037 ID - Johnson2007 ER - TY - JOUR AU - Smyth, G. K. PY - 2004 DA - 2004// TI - Linear models and empirical bayes methods for assessing differential expression in microarray experiments JO - Stat Appl Genet Mol Biol VL - 3 ID - Smyth2004 ER - TY - JOUR AU - Storey, J. D. AU - Tibshirani, R. PY - 2003 DA - 2003// TI - Statistical significance for genomewide studies JO - Proc Natl Acad Sci U S A VL - 100 UR - https://doi.org/10.1073/pnas.1530509100 DO - 10.1073/pnas.1530509100 ID - Storey2003 ER - TY - JOUR AU - Stocher, M. AU - Berg, J. PY - 2004 DA - 2004// TI - Internal control DNA for PCR assays introduced into lambda phage particles exhibits nuclease resistance JO - Clin Chem VL - 50 UR - https://doi.org/10.1373/clinchem.2004.035519 DO - 10.1373/clinchem.2004.035519 ID - Stocher2004 ER - TY - JOUR AU - Sarkioja, M. AU - Pesonen, S. AU - Raki, M. AU - Hakkarainen, T. AU - Salo, J. AU - Ahonen, M. T. PY - 2008 DA - 2008// TI - Changing the adenovirus fiber for retaining gene delivery efficacy in the presence of neutralizing antibodies JO - Gene Ther VL - 15 UR - https://doi.org/10.1038/gt.2008.56 DO - 10.1038/gt.2008.56 ID - Sarkioja2008 ER -